Management team for macular degeneration research, dry AMD treatment and clinical trials
Philip G. Ralston, Jr.
Philip G. Ralston, Jr., has spent more than 35 years in the life science industry as a senior executive, inventor, company founder, venture capitalist and business coach. He has represented companies in public, private and non-profit sectors.- read more
Douglas R. Baum
With more than 18 years of experience in the pharmaceutical development industry, Douglas Baum has been directly involved with the development of over 15 FDA approved and marketed drugs.- read more